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Abstract
Joint models for longitudinal and survival data have gained a lot of attention in recent years, with the development of myriad
extensions to the basic model, including those which allow for multivariate longitudinal data, competing risks and recurrent
events. Several software packages are now also available for their implementation. Although mathematically straightforward,
the inclusion of multiple longitudinal outcomes in the joint model remains computationally difficult due to the large number of
random effects required, which hampers the practical application of this extension. We present a novel approach that enables
the fitting of such models with more realistic computational times. The idea behind the approach is to split the estimation of
the joint model in two steps: estimating a multivariate mixed model for the longitudinal outcomes and then using the output
from this model to fit the survival submodel. So-called two-stage approaches have previously been proposed and shown to be
biased. Our approach differs from the standard version, in that we additionally propose the application of a correction factor,
adjusting the estimates obtained such that they more closely resemble those we would expect to find with the multivariate
joint model. This correction is based on importance sampling ideas. Simulation studies show that this corrected two-stage
approach works satisfactorily, eliminating the bias while maintaining substantial improvement in computational time, even
in more difficult settings.
Keywords Biomarkers · Importance sampling · Multivariate random effects
1 Introduction
Joint models for longitudinal and survival data have become
a valuable asset in the toolbox of modern data scientists.
After the seminal papers of Faucett and Thomas (1996)
and Wulfsohn and Tsiatis (1997), several extensions of
these models have been proposed in the literature. These
include, among others, flexible specification of the longitudi-
nal model (Brown et al. 2005a), consideration of competing
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risks (Elashoff et al. 2008; Andrinopoulou et al. 2014) and
multistate models (Ferrer et al. 2016), and the calcula-
tion of dynamic predictions (Proust-Lima and Taylor 2009;
Rizopoulos 2011; Rizopoulos et al. 2014; Andrinopoulou
and Rizopoulos 2016; Rizopoulos et al. 2017; Andrinopoulou
et al. 2018). A particularly useful and practical extension is
the one which allows for the inclusion of multiple longitudi-
nal outcomes (Rizopoulos and Ghosh 2011a; Chi and Ibrahim
2006; Brown et al. 2005b; Lin et al. 2002). In medical set-
tings in particular, data collection is likely to be complex:
while the standard joint model allows us to determine the
association between a survival outcome and a single longi-
tudinal outcome (biomarker), there are more often than not
multiple biomarkers relevant to the event of interest. Extend-
ing the univariate joint model to accommodate these multiple
longitudinal outcomes allows us to incorporate more infor-
mation, improving prognostication and enabling us to better
make sense of the complex underlying nature of the disease
dynamics. A motivating example of this is the Bio-SHiFT
cohort study; a prospective observational study conducted
in the Netherlands on chronic heart failure (CHF) patients.
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The primary focus of the study was to determine whether or
not disease progression in individual CHF patients can be
assessed using longitudinal measurements of several blood
biomarkers (van Boven et al. 2018). Previous work on this
data has focused mainly on the association between each
individual biomarker and a single composite event, but it is
likely that the predictive value of the biomarkers will be more
accurately determined when they are assessed in concert.
Extension to the multivariate case is mathematically
straightforward and may be easily combined with other
extensions: allowing for longitudinal outcomes of varying
types, left, right and interval censoring and the inclusion
of competing risks, among others. There are also now a
number of excellent software packages available, which
makes the implementation of the more complex models
easier. There are, however, technical challenges which ham-
per the widespread use of these models. As the number
of longitudinal outcomes increases, and thus the number
of random effects, standard methods become computation-
ally prohibitive: under a Bayesian approach, the number of
parameters to sample becomes unreasonably large, and in the
case of maximum likelihood, we are required to numerically
approximate the integrals over the random effects, which
is challenging in high dimensions. The practical solution
most commonly used in such settings is that of the two-stage
approach, wherein a multivariate mixed model is first used
for the longitudinal outcomes, following which, the output
of this model is used to fit a survival submodel. Unfortu-
nately, substantial research on this topic indicates that this
approach results in biased estimates (Tsiatis and Davidian
2004; Rizopoulos 2012; Ye et al. 2008). In this paper, we pro-
pose an adaptation of the simple two-stage approach, which
eliminates the bias and substantially reduces computational
time. We propose the use of a correction factor, based on
importance sampling theory (Press et al. 2007, Section 7.9).
This correction factor allows us to re-weight each realization
of the MCMC sample obtained from the Bayesian estimation
of the two-stage approach such that the resulting estimates
more closely approximate those obtained via the full mul-
tivariate joint model. The weights are given by the target
distribution (the full posterior distribution of the multivariate
joint model), divided by the product of the posterior distribu-
tions for each of the two stages, evaluated for each iteration
of the MCMC sample. The use of this correction factor alone
is not enough to eliminate the bias, but, prior to its applica-
tion, the two-stage approach is itself modified: where before,
in the second stage, only the parameters of the survival sub-
model were updated, we now also update the random effects.
These adaptations combined achieve unbiased estimates in a
fraction of the time required to compute the full multivariate
model.
The rest of the paper is organized as follows: Sect. 2
introduces the full multivariate joint model, and Sect. 3
discusses the estimation of the model under the Bayesian
paradigm. Section 4 introduces the importance-sampling-
corrected two-stage approach and presents the results of a
simple simulation, and Sect. 5 introduces the importance-
sampling-corrected two-stage approach with updated ran-
dom effects. Section 6 presents the results of a more complex
simulation, and finally in Sect. 7, we look at an analysis of
the Bio-SHiFT data.
2 Joint model speciﬁcation
We start with a general definition of the framework of multi-
variate joint models for multiple longitudinal outcomes and
an event time.
Let Dn = {Ti , T Ui , δi , yi ; i = 1, . . . , n} denote a sample
from the target population, where T ∗i denotes the true event
time for the i th subject and Ti and T Ui the observed event
times. Then, δi ∈ {0, 1, 2, 3} denotes the event indicator,
with 0 corresponding to right censoring (T ∗i > Ti ), 1 to a
true event (T ∗i = Ti ), 2 to left censoring (T ∗i < Ti ) and 3 to
interval censoring (Ti < T ∗i < T Ui ). Assuming K longitu-
dinal outcomes, we let yki denote the nki × 1 longitudinal
response vector for the kth outcome (k = 1, . . . , K ) and the
i th subject, with elements yki j denoting the value of the kth
longitudinal outcome for the i th subject, taken at time point
tki j , j = 1, . . . , nki .
To accommodate multivariate longitudinal responses of
different types in a unified framework, we postulate a general-
ized linear mixed-effects model. In particular, the conditional
distribution of yki given a vector of random effects bki is
assumed to be a member of the exponential family, with lin-
ear predictor given by
gk
[
E{yki (t) | bki }
] = ηki (t) = xki (t)βk + zki (t)bki (1)
where gk(·) denotes a known one-to-one monotonic link
function, yki (t) denotes the value of the kth longitudinal
outcome for the i th subject at time point t and xki (t) and
zki (t) denote the design vectors for the fixed effects βk and
the random effects bki , respectively. The dimensionality and
composition of these design vectors are allowed to differ
between the multiple outcomes, and they may also contain
a combination of baseline and time-varying covariates. To
account for the association between the multiple longitudi-
nal outcomes, we link their corresponding random effects.
More specifically, the complete vector of random effects bi =
(b1i , b2i , . . . , bK i ) is assumed to follow a multivariate nor-
mal distribution with mean zero and variance-covariance
matrix D.
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For the survival process, we assume that the risk for an
event depends on a function of the subject-specific linear
predictor ηi (t) and/or the random effects. More specifically,
we have
hi (t | Hi (t),wi (t))
=
lim
Δt→0 Pr{t ≤ T ∗i < t + Δt | T ∗i ≥ t,Hi (t),wi (t)}
Δt
, t > 0
= h0(t) exp
[
γ wi (t) +
K∑
k=1
Lk∑
l=1
fkl{Hki (t),wi (t), bki ,αkl}
]
,
(2)
where Hki (t) = {ηki (s), 0 ≤ s < t} denotes the history of
the underlying longitudinal process up to t for outcome k
and subject i , h0(·) denotes the baseline hazard function and
wi (t) is a vector of exogenous, possibly time-varying, covari-
ates with corresponding regression coefficients γ . Functions
fkl(·), parameterized by vector αkl , specify which compo-
nents/features of each longitudinal outcome are included
in the linear predictor of the relative risk model, (Brown
(2009), Rizopoulos and Ghosh (2011b), Rizopoulos (2012),
Rizopoulos et al. (2014)). Some examples, motivated by the
literature, are (subscripts kl have been dropped in the follow-
ing expressions but are assumed):
f {Hi (t),wi (t), bi ,α} = αηi (t),
f {Hi (t),wi (t), bi ,α} = α1ηi (t) + α2η′i (t),
η′i (t) =
dηi (t)
dt
,
f {Hi (t),wi (t), bi ,α} = α
∫ t
0
ηi (s) ds.
These formulations of f (·) postulate that the hazard of an
event at time t may be associated with the underlying level
of the biomarker at the same time point, the slope of the lon-
gitudinal profile at t or the accumulated longitudinal process
up to t . In addition, the specified terms from the longitudinal
outcomes may also interact with some covariates in the wi (t).
Furthermore, note that we allow a combination of Lk func-
tional forms per longitudinal outcome. Finally, the baseline
hazard function h0(·) is modeled flexibly using a B-splines
approach, i.e.,
log h0(t) =
Q∑
q=1
γh0,q Bq(t, v), (3)
where Bq(t, v) denotes the qth basis function of a B-spline
with knots v1, . . . , vQ and γ h0 the vector of spline coeffi-
cients; typically, Q = 15 or 20.
3 Likelihood and priors
As explained in Sect. 1, we use a Bayesian approach for the
estimation of the joint model’s parameters. The posterior dis-
tribution of the model parameters given the observed data is
derived under the assumptions that given the random effects,
the longitudinal outcomes are independent from the event
times, the multiple longitudinal outcomes are independent
of each other and the longitudinal responses of each subject
in each outcome are independent. Under these assumptions,
the posterior distribution is analogous to:
p(θ, b) ∝
n∏
i=1
K∏
k=1
nki∏
j=1
p(yki j | bki , θ)p(Ti , T Ui , δi | bki , θ)
× p(bi | θ)p(θ), (4)
where θ denotes the full parameter vector, and
p(yki j | θ , bki ) = exp
⎧
⎨
⎩
[
yki jψki j (bki ) − ck{ψki j (bki )}
]
ak(ϕ) − dk(yki j , ϕ)
⎫
⎬
⎭
,
with ψki j (bki ) and ϕ denoting the natural and dispersion
parameters in the exponential family, respectively, and ck(·),
ak(·) and dk(·) are known functions specifying the member
of the exponential family. For the survival part, accordingly
we have
p(Ti , T Ui , δi | bi , θ) =
{
hi (Ti | Hi (Ti ),wi (Ti ))
}I (δi =1)
× exp
{
−
∫ Ti
0
hi (s | Hi (s),wi (s)) ds
}I (δi ∈{0,1})
×
{
1 − exp
{
−
∫ Ti
0
hi (s | Hi (s),wi (s)) ds
}}I (δi =2)
×
{
exp
{
−
∫ Ti
0
hi (s | Hi (s),wi (s)) ds
}
− exp
{
−
∫ T Ui
0
hi (s | Hi (s),wi (s)) ds
}}I (δi =3)
, (5)
where I (·) denotes the indicator function. The integral in
the definition of the cumulative hazard function does not
have a closed-form solution, and thus a numerical method is
employed for its evaluation. Standard options are the Gauss–
Kronrod and Gauss–Legendre quadrature rules.
For the parameters of the longitudinal outcomes, we use
standard default priors. The covariance matrix of the random
effects is parameterized in terms of a correlation matrix Ω
and a vector of σ d . For the correlation matrix Ω , we use
the LKJ-Correlation prior proposed by Lewandowski et al.
(2009) with parameter ζ = 1.5. For each element of σ d , we
use a half-Student’s t prior with three degrees of freedom.
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For the regression coefficients γ of the relative risk model,
we assume independent normal priors with zero mean and
variance 1000. The same prior is also assumed for the vec-
tor of association parameters α. However, when α becomes
high dimensional (e.g., when several functional forms are
considered per longitudinal outcome), we opt for a global–
local ridge-type shrinkage prior. More specifically, for the
sth element of α, we assume:
αs ∼ N (0, τψs),
τ−1 ∼ Gamma(0.1, 0.1),
ψ−1s ∼ Gamma(1, 0.01).
The global smoothing parameter τ has sufficient mass near
zero to ensure shrinkage, while the local smoothing param-
eter ψs allows individual coefficients to attain large values.
The motivation for using this type of prior distribution in
this case is that we expect the different terms behind the
specification of f (·) to be correlated and many of the cor-
responding coefficients to be nonzero. Nonetheless, other
options of shrinkage or variable-selection priors could also
be used (Andrinopoulou and Rizopoulos 2016). Finally, the
penalized version of the B-spline approximation to the base-
line hazard is specified using the following hierarchical prior
for γ h0 (Lang and Brezger 2004):
p(γ h0 | τh) ∝ τρ(K )/2h exp
(
−τh
2
γ h0 Kγ h0
)
,
where τh is the smoothing parameter that takes a Gamma
(1, τhδ) prior distribution, with a hyper-prior τhδ ∼ Gamma
(10−3, 10−3), which ensures a proper posterior distribution
for γ h0 (Jullion and Lambert 2007), K = Δr Δr + 10−6I,
with Δr denoting the r th difference penalty matrix and where
ρ(K ) denotes the rank of K .
4 Corrected two-stage approach
4.1 Importance sampling correction
Carrying out a full Bayesian estimation of the multivariate
joint model is straightforward, using either Markov chain
Monte Carlo (MCMC) or Hamiltonian Monte Carlo (HMC).
However, this estimation becomes very challenging from a
computational viewpoint, due to the high number of random
effects involved and the requirement for numerical integra-
tion in the calculation of the density of the survival outcome
(5). This limitation has hampered the use of multivariate joint
models in practice.
The two-stage approach, which entails fitting the longitu-
dinal and survival outcomes separately, is the solution most
often used to overcome this computational deadlock. Using
this approach, under the Bayesian framework, we would have
the following two stages:
S-I: We fit a multivariate mixed model for the longitudinal
outcomes using either MCMC or HMC, and we obtain
a sample {θ (m)y , b(m); m = 1, . . . , M} of size M from
the posterior,
p(θ y, b | y) ∝
n∏
i=1
K∏
k=1
nki∏
j=1
p(yki j | bki , θ) p(bi | θ) p(θ y),
where θ y denotes the subset of the parameters that are
included in the definition of the longitudinal submodels
(including the parameters in the random effects distribution).
S-II: Utilizing the sample from Stage I, we obtain a sample
for the parameters of the survival submodel {θ (m)t ; m =
1, . . . , M} from the corresponding posterior distribu-
tion,
p(θ t | T˜ , δ, θ (m)y , b(m))∝
n∏
i=1
p(T˜i , δi | θ t , b(m)i , θ (m)y ) p(θ t ),
where θ t denotes the subset of the parameters that are
included in the definition of the survival submodel, and
T˜ = (T , T U ).
This two-stage procedure essentially entails the same
number of iterations as the full Bayesian estimation of the
multivariate joint model. The computational benefits stem
from the fact that we do not need to numerically integrate the
survival submodel density function in Stage I. Even though
this approach greatly reduces the computational burden, there
exists a substantial body of work demonstrating that it results
in biased estimates, even in the simpler case of univariate
joint models (see Tsiatis and Davidian 2004; Rizopoulos
2012, and references therein). This bias is a result of not
working with the full joint distribution, which would pro-
duce estimates of θ y and b that are appropriately corrected
for informative dropout relating to the occurrence of an event.
To overcome this issue, we propose the correction of
the estimates we obtain from the two-stage approach using
importance sampling weights (Press et al. 2007, Sec-
tion 7.9). In particular, we consider that the realizations
{θ (m)t , θ (m)y , b(m); m = 1, . . . , M} that we have obtained
using the two-stage approach can be considered a weighted
sample from the full posterior of the multivariate joint model
with weights given by:
w(m) = p(θ
(m)
t | T˜ , δ, θ (m)y , b(m)) p(θ (m)y , b(m)|y, T˜ , δ)
p(θ (m)t | T˜ , δ, θ (m)y , b(m)) p(θ (m)y , b(m) | y)
.
(6)
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The numerator in this expression is the posterior distribu-
tion of the multivariate joint model, and the denominator, the
corresponding posterior distributions from each of the two
stages. As previously stated, from (6) we observe that the
difference between fitting the full joint model versus the two-
stage approach comes from the second term in the numerator
and denominator. By expanding these two terms, we obtain
p(θ (m)y , b | y, T˜ , δ)
p(θ (m)y , b(m) | y)
∝
(∏
i p( yi | b(m)i , θ (m)y ) p(T˜i , δi | b(m)i , θ (m)y )
. . . × p(b(m)i | θ (m)y ) p(θ (m)y )
)
∏
i p( yi | b(m)i , θ (m)y ) p(b(m)i | θ (m)y ) p(θ (m)y )
=
∏
i
p(T˜i , δi | b(m)i , θ (m)y )
=
∏
i
∫
p(T˜i , δi | b(m)i , θ (m)y , θ t ) dθ t . (7)
The resulting weights involve a marginal likelihood cal-
culation, which we perform using a Laplace approximation,
namely
(m) = exp
[q log(2π) − log{det(Σ̂(m))}
2
+ log{p(T˜i , δi | b(m)i , θ (m)y , θ̂ (m)t )}
]
,
w˜(m) = (m)
/ M∑
m=1
(m),
where
θ̂
(m)
t = arg max
θ t
[
log{p(T˜i , δi | b(m)i , θ (m)y , θ̂ t )}
]
,
det(A) denotes the determinant of matrix A,
Σ̂(m)= −∂2 log{p(T˜i , δi | b(m)i , θ (m)y , θ̂ t )}
/
∂θt ∂θ t
∣∣
θt=θˆ (m)t ,
and q denotes the dimensionality of the θ t vector. The extra
computational burden of performing this Laplace approxi-
mation is minimal in practice, since good initial values can
be provided from one iteration m to the next m + 1, which
substantially reduces the number of required optimization
iterations for finding θ̂ (m)t (i.e., θ̂
(m)
t is provided as an initial
value to find θ̂ (m+1)t ).
4.2 Performance
To evaluate whether the introduction of the importance sam-
pling weights alleviates the bias observed with the simple
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Fig. 1 Simulation results from 500 datasets comparing the two-stage
approach and the importance-sampling-corrected two-stage approach
with the full joint model for continuous longitudinal outcomes. The
three panels show posterior means from the 500 datasets for the three
coefficients in the survival submodel, namely the coefficient for the
baseline group variable and the association parameters for the two lon-
gitudinal outcomes. The dashed horizontal line indicates the true value
of the coefficients
two-stage approach (i.e., without the weights), we perform a
‘proof-of-concept’ simulation study. In particular, we com-
pare the proposed corrected two-stage approach with the
simple two-stage approach, as well as the full multivariate
joint model in the case of two continuous longitudinal out-
comes. The specific details of this simulation setting are given
in “Appendix A.1.” The results from 500 simulated datasets
are presented in Fig. 1 and in the appendix, in Figs. 4 and 5.
Figure 4 shows boxplots with the computing times required
to fit the joint model under three approaches. Comparing
the first two of these approaches, we see that the calculation
of the importance sampling weights in the corrected two-
stage approach had minimal computational cost, with the
full multivariate joint model taking substantially more time
to fit. Figure 5 shows boxplots of posterior means from the
500 datasets for the parameters of the two longitudinal sub-
models. We observe that all three approaches provide very
similar results with minimal bias. Figure 1 shows the cor-
responding boxplots of posterior means for the parameters
of the survival submodel. As expected, the full multivariate
joint model returns unbiased results. Similarly, as has pre-
viously been reported in the literature, the simple two-stage
approach exhibits considerable bias. We see that this bias
persists for the corrected two-stage approach, although theo-
retically the use of the importance sampling weights should
alleviate it (by adjusting the posterior means obtained via
the simple two-stage approach such that they more closely
resemble those from the full multivariate model).
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cepts and random slopes from one simulated dataset for the first
longitudinal outcome between a linear mixed model and a joint model.
The left column panels correspond to all subjects, the middle column
to subjects without an event and the right column panel to subjects with
an event
5 Corrected two-stage approach with
random eﬀects
5.1 Importance sampling correction with random
effects
The above result is unexpected, since (as per Fig. 5), the cor-
rected two-stage (and indeed the simple two-stage) approach
unbiasedly estimates both the fixed effects and the variance
components of the longitudinal submodels. However, further
investigation shows that there is a considerable difference
between the corrected two-stage approach and the multivari-
ate joint model with regard to the posterior of the random
effects. This is depicted in Fig. 2 for one of the longitudinal
outcomes we have simulated. The data have been simulated
such that higher values for longitudinal outcome y1 are asso-
ciated with a higher hazard of the event. From Fig. 2, we
observe that the random effect estimates for the multivariate
mixed model and, in particular, the random slope estimates
for subjects with and without an event differ from those for
the multivariate joint model. In particular, we observe that the
random slope estimates from the joint model are larger for
subjects with an event compared to the linear mixed model,
and vice versa for subjects without an event. This observa-
tion suggests that we could improve the weights given in (6)
by updating (in the second stage) not only the parameters of
the survival submodel θ t but also the random effects b. That
is, we obtain a sample for the parameters of the survival sub-
model {θ (m)t , b(m); m = 1, . . . , M} from the corresponding
joint posterior distribution,
p(θ t , b | T˜ , δ, y, θ (m)y )
∝
n∏
i=1
K∏
k=1
nki∏
j=1
p(yki j | bki , θ (m)y ) p(bi | θ (m)y )
× p(T˜i , δi | θ t , bi , θ (m)y ) p(θ t ). (8)
Admittedly, simulating from [θ t , b | T˜ , δ, y, θ (m)y ] is
more computationally intensive than simulating from [θ t |
T˜ , δ, θ (m)y , b(m)], the corresponding second stage presented
in Sect. 4, since we now also need to calculate the densities
of the mixed-effect models for the K longitudinal outcomes.
Nonetheless, the computational gains compared to fitting the
full joint model remain significant.
Under this second stage (8), the importance sampling
weights now take the form:
w(m) = p(θ
(m)
t , b(m) | T˜ , δ, y, θ (m)y ) p(θ (m)y | y, T˜ , δ)
p(θ (m)t , b(m) | T˜ , δ, y, θ (m)y ) p(θ (m)y , b(m) | y)
. (9)
Similarly to (6), the new weights have been formulated
such that the difference lies in the second term in both the
numerator and denominator. By doing an expansion of these
two terms similar to that used in the previous section, we
obtain:
w(m) = p(θ
(m)
y | y, T˜ , δ)
p(θ (m)y , b(m) | y)
∝ (m) =
∏
i p( yi , T˜i , δi | θ (m)y ) p(θ (m)y )
∏
i p( yi | b(m)i , θ (m)y ) p(b(m)i | θ (m)y ) p(θ (m)y )
=
(∏i
∫ ∫
p( yi | bi , θ (m)y )p(T˜i , δi | bi , θ (m)y , θ t )
. . . × p(bi | θ (m)y ) p(θ t ) dbi dθ t
)
∏
i p( yi | b(m)i , θ (m)y ) p(b(m)i | θ (m)y )
,
(10)
and the self-normalized weights are
w˜(m) = (m)
/∑
m
(m).
The integrals in the numerator are once again approxi-
mated using the Laplace method; namely, we let
{̂
θ

t , b̂

i
} = arg max
θt ,bi
{∑
j
log p(yi j | bi , θ (m)y )
+ log p(T˜i , δi | bi , θ (m)y , θ t )
+ log p(bi | θ (m)y ) + log p(θ t )
}
,
and
Σbi = −
(∂2
{
log p( yi | bi , θ (m)y )
. . . + log p(T˜i , δi | bi , θ (m)y , θ̂ t )
. . . + log p(bi | θ (m)y )
}
)
∂b∂b
∣∣∣
b=bˆi
,
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denote the Hessian matrix for the random effects, and anal-
ogously,
Σθt = −
∂2
∑
i
{
log p(T˜i , δi | b̂i , θ (m)y , θ t )+ log p(θ t )
}
∂θt ∂θ t
∣∣∣
θt=θˆt
,
denote the Hessian matrix for the θ t parameters. Then, we
approximate the inner integral by
p( yi , T˜i , δi | θ (m)y , θ̂ t )
≈ exp
[
κ log(2π) − log{det(Σbi )
}
2
+ log p( yi | b̂i , θ (m)y ) + log p(T˜i , δi | b̂i , θ (m)y , θ̂ t )
+ log p(̂bi | θ (m)y )
]
,
where κ denotes the number of random effects for each sub-
ject i . Similarly, the outer integral is approximated as
p( yi , T˜i , δi | θ (m)y )
≈ exp
[q log(2π) − log{det(Σθ )
}
2
+
∑
i
log p( yi , T˜i , δi | θ (m)y , θ̂ t )
]
.
Given the requirement for a double Laplace approxima-
tion, and the fact that the denominator does not simplify,
the calculation of the (m) weights given by (10) is more
computationally intensive than the ones presented in Sect. 4.
Nevertheless, these required computations still remain many
orders of magnitude faster than fitting the full joint model.
5.2 Performance
To assess whether updating the random effects in the impor-
tance sampling weights alleviates the bias we observed in
Sect. 4.2, we have re-analyzed the same simulated datasets.
The details are again given in “Appendix A.1.”. The results
from 500 simulated datasets are presented in Figs. 3, 4
and 6. As anticipated, the corrected two-stage approach with
updated random effects added only a small computational
cost, with the full multivariate joint model still taking consid-
erably more time to fit than either of the corrected two-stage
approaches (Fig. 4). The boxplots depicting the posterior
means from the 500 datasets for the parameters of the lon-
gitudinal submodels once again demonstrate similar results
for all three approaches (Fig. 6). Figure 3 shows the pos-
terior means for the parameters of the survival submodel.
We observe that the bias seen for the corrected two-stage
approach is now eliminated, with the posterior means from
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Fig. 3 Simulation results from 500 datasets comparing the importance-
sampling-corrected two-stage approach and the corrected two-stage
approach with random effects with the full joint model for continuous
longitudinal outcomes. The three panels show posterior means from the
500 datasets for the three coefficients in the survival submodel, namely
the coefficient for the baseline group variable and the association param-
eters for the two longitudinal outcomes. The dashed horizontal line
indicates the true value of the coefficients
the approach with updated random effects closely approxi-
mating those from the full multivariate joint model.
6 Extra simulations
Further simulations were performed in order to assess the per-
formance of the importance-sampling-corrected two-stage
approach with the updated random effects, in different sce-
narios. Details of these simulations are given in Appendices
A.2 and A.3.
6.1 Scenario II
Scenario II included six continuous longitudinal outcomes.
Owing to the increased number of outcomes, the full multi-
variate joint model was not run. Table 1 shows the bias for
the parameters of the survival submodel, together with the
RMSE and coverage (based on the 2.5% and 97.5% credi-
bility intervals for each parameter). Table 4 in the appendix
shows the same information for the parameters of the six
longitudinal outcomes.
6.2 Scenario III
Scenario III again included six longitudinal outcomes, now
of varying types: three continuous and three binary. Table 2
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Table 1 Simulation results for parameters of the survival submodel
(Scenario II)
Parameter True value Bias RMSE Coverage
Group − 0.20 − 0.02 0.19 0.96
α1 1.09 − 0.01 0.04 0.93
α2 − 1.09 0.01 0.04 0.93
α3 − 0.92 − 0.01 0.16 0.95
α4 0.92 0.03 0.17 0.95
α5 0.43 0.03 0.05 0.83
α6 − 0.43 − 0.02 0.04 0.88
Table 2 Simulation results for parameters of the survival submodel
(Scenario III)
Parameter True value Bias RMSE Coverage
Group − 0.47 − 0.01 0.91 0.97
α1 0.17 − 0.01 0.04 1.00
α2 − 0.17 0.01 0.04 1.00
α3 0.17 0.00 0.43 0.90
α4 − 0.17 0.02 0.88 0.96
α5 0.47 0.02 0.04 1.00
α6 − 0.47 − 0.01 0.05 0.99
demonstrates yet again the alleviation of the bias achieved
by updating the random effects.
7 Analysis of the Bio-SHiFT dataset
In this section, we present the analysis of data from the
Bio-SHiFT cohort study. During a median follow-up period
of 2.4 years (IQR: 2.32–2.45), estimated using the reverse
Kaplan–Meier methodology (Shuster 1991), 66/254 (26%)
patients experienced the primary event of interest (a com-
posite event, consisting of hospitalization for heart failure,
cardiac death, LVAD placement and heart transplantation).
Biomarkers were measured at inclusion and subsequently
every 3 months until the end of follow-up. We focus on six
biomarkers: the glomerular marker cystatin C (CysC), two
tubular markers: urinary N-acetyl-beta-D-glucosaminidase
(NAG) and kidney injury molecule (KIM)-1, and the mark-
ers N-terminal propBNP (NT-proBNP), cardiac troponin T
(HsTNT) and C-reactive protein (CRP). The latter three
markers are known to be related to poor outcomes in CHF
patients and measure various aspects of heart failure patho-
physiology (wall stress, myocyte damage and inflammation,
respectively). All biomarkers were logarithmically trans-
formed for further analysis (log base 2) due to skewness.
For each of NT-probnp, HsTNT and CRP, we included nat-
ural cubic splines in both the fixed and random effects parts of
their longitudinal models, with differing numbers of knots per
outcome (Fig. 7). Simple linear models with random inter-
cept and slope were used for CysC, NAG and KIM-1. Thus,
for each of CysC, NAG and KIM-1 (k = 1, 2, 3), we fit:
E{yki (t) | bki } = βk0 + bki0 + (βk1 + bki1) × time.
For the remaining outcomes (k = 4, 5, 6), we have:
E{yki (t) | bki } = (βk0 + bki0) +
∑
pk
(βkpk + bkipk )Bkn(t, λpk ),
where Bkn(t; λpk ) denotes the B-spline basis matrix for a
natural cubic spline of time with two internal knots placed at
the 25th and 75th percentiles of the follow-up times for NT-
probnp (p = 1, 2, 3) and one internal knot placed at the 50th
percentile of the follow-up times for each of HsTNT and CRP
(p = 1, 2). Boundary knots were set at the fifth and 95th per-
centiles. We assume a multivariate normal distribution for the
random effects, bi = (bT1i , bT2i , . . . , bT6i )T ∼ MV N (0, D),
where D is a 16×16 unstructured variance covariance matrix.
For the survival process, we included the baseline variables:
(standardized) age, sex, NYHA class (class III / IV vs. class
I / II), use of diuretics, presence or absence of ischemic heart
disease (IHD), diabetes mellitus, (standardized) BMI and the
estimated glomerular filtration rate (eGFR) value.
We fit three joint models, using the global–local ridge-type
shrinkage prior previously described in each case. Model 1
included only the current underlying value of the longitudinal
marker for each of the six markers. Model 2 included the
current value and slope for each marker, and model 3 included
the integrated longitudinal profile for each marker (AUC). We
thus have:
Model 1: hi (t) = h0(t) exp
[
γwi (t) +
K∑
k=1
αkηki (t)
]
,
Model 2: hi (t) = h0(t) exp
[
γwi (t) +
K∑
k=1
α1kηki (t) +
K∑
k=1
α2kη
′
ki (t)
]
,
Model 3: hi (t) = h0(t) exp
[
γwi (t) +
K∑
k=1
αk
∫ t
0
ηki (s) ds
]
.
The parameter estimates and 95% credibility intervals for
the event process are presented in Table 3. Hazard ratios are
presented per doubling of level, slope or AUC at any point
in time. Following adjustment for covariates, the estimated
association parameters in Model 1 indicate significant associ-
ations between the risk of the composite event and the current
underlying values of NT-proBNP and CRP, such that there
is a 1.86-fold increase in the risk of the composite event
(95% CI: 1.45 to 2.37), per doubling of NT-probnp level,
and a 1.44-fold increase in the risk of the composite event
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Table 3 Parameter estimates and 95% credibility intervals under the
joint modeling analysis for the Bio-SHiFT data
Event process
HR (95% CI) HR* p value
Model 1: Current value
Age 1.01 (0.99 to 1.03) 1.00 0.242
Sex (male vs. female) 1.00 (0.77 to 1.31) 1.06 0.970
NYHA Class (III/IV vs. I/II) 1.47 (0.97 to 2.64) 2.52 0.134
Diuretics (Yes vs. no) 1.12 (0.79 to 2.74) 0.96 0.770
IHD (Yes vs. no) 1.06 (0.88 to 1.55) 0.95 0.696
eGFR 1.01 (1.00 to 1.02) 1.01 0.048
BMI 1.04 (0.99 to 1.10) 1.03 0.140
Diabetes mellitus 1.08 (0.86 to 1.79) 0.93 0.638
αC R P 1.44 (1.10 to 1.89) 1.25 0.008
αHsT N T 1.32 (0.99 to 1.84) 1.35 0.078
αN T −proB N P 1.86 (1.45 to 2.37) 2.20 <0.0001
αCysC 1.04 (0.55 to 2.48) 0.90 0.966
αN AG 0.89 (0.51 to 1.38) 0.55 0.660
αK I M−1 0.96 (0.74 to 1.22) 1.21 0.768
Model 2: Current value and slope
Age 1.01 (0.99 to 1.03) 1.00 0.162
Sex (male vs. female) 0.99 (0.66 to 1.34) 0.91 0.994
NYHA Class (III/IV vs. I/II) 1.61 (0.97 to 2.97) 1.53 0.104
Diuretics (Yes vs. no) 1.20 (0.79 to 4.64) 0.95 0.736
IHD (Yes vs. no) 1.06 (0.84 to 1.56) 1.36 0.750
eGFR 1.01 (1.00 to 1.02) 1.01 0.090
BMI 1.04 (0.98 to 1.10) 1.08 0.236
Diabetes mellitus 1.08 (0.84 to 1.73) 1.03 0.676
αC R P value 1.52 (1.19 to 1.99) 1.38 0.002
αHsT N T value 1.37 (1.00 to 1.89) 1.08 0.048
αN T −proB N P value 1.90 (1.48 to 2.44) 1.61 <0.0001
αCysC value 1.05 (0.47 to 3.20) 0.92 0.996
αN AG value 0.74 (0.36 to 1.22) 1.04 0.292
αK I M−1 value 0.92 (0.69 to 1.18) 1.02 0.534
αC R P slope 0.95 (0.55 to 1.50) 0.91 0.878
αHsT N T slope 0.84 (0.24 to 1.91) 1.05 0.734
αN T −proB N P slope 1.02 (0.70 to 1.48) 0.87 0.926
αCysC slope 1.75 (0.19 to 356.56) 1.35 0.826
αN AG slope 1.03 (0.08 to 6.63) 0.84 0.946
αK I M−1 slope 2.37 (0.61 to 63.48) 0.93 0.460
Model 3: AUC
Age 1.00 (0.98 to 1.03) 1.01 0.812
Sex 1.02 (0.83 to 1.38) 1.00 0.944
NYHA class (III/IV vs. I/II) 1.80 (0.99 to 3.25) 1.83 0.080
Diuretics (Yes vs. no) 1.18 (0.83 to 3.72) 1.22 0.680
IHD (Yes vs. no) 1.04 (0.85 to 1.40) 1.21 0.742
eGFR 1.01 (1.00 to 1.02) 1.00 0.166
BMI 1.03 (0.98 to 1.08) 1.02 0.286
Table 3 continued
Event process
HR (95% CI) HR* p value
Diabetes mellitus 1.11 (0.89 to 1.87) 0.99 0.564
αC R P 1.18 (0.99 to 1.43) 1.10 0.064
αHsT N T 1.20 (0.98 to 1.56) 1.06 0.082
αN T −proB N P 1.47 (1.21 to 1.79) 1.50 <0.0001
αCysC 1.13 (0.73 to 2.60) 1.38 0.704
αN AG 0.96 (0.63 to 1.34) 1.12 0.846
αK I M−1 1.00 (0.82 to 1.19) 1.01 0.960
Hazard ratios are presented per doubling of level, slope or AUC at any
point in time. HR* is the estimate after importance sampling
(95% CI: 1.1 to 1.89), per doubling of CRP level. No signifi-
cant associations were found for any of HsTNT, CysC, NAG
or KIM-1. Similarly, no significant associations were found
for the current underlying values of CysC, NAG or KIM-1
in Model 2, and nor were there any significant associations
between the risk of the composite event and the slopes of the
six continuous markers.
Model 3 indicates a significant association for NT-
proBNP, with a 1.47-fold increase in the risk of the composite
event (95% CI: 1.21 to 1.79) per doubling of the area under
the NT-proBNP profile.
Since the parameter estimates for each of the longitudinal
outcomes remained fairly constant across models, to avoid
repetition, the estimates and 95% credibility intervals are
presented for one model only (Table 7).
In previous analyses of these same six markers, the cur-
rent underlying value, instantaneous slope and area under the
curve of each marker were each assessed independently of
one another. Van Boven et al., 2018 found significant asso-
ciations in all cases for CRP, HsTNT and NT-proBNP, and
Brankovic et al., 2018 found significant associations for the
current underlying values and slopes of each of CysC, NAG
and KIM-1, and the area under the curves for CysC, and
NAG.
Van Boven et al., 2018, provided an additional multi-
variate analysis for CRP, HsTNT and NT-proBNP, wherein
the predicted individual profiles for each marker were sepa-
rately determined, and functions thereof were simultaneously
included in a single extended Cox model as time-varying
covariates. Models therefore included either the current
underlying values, the instantaneous slopes or the area under
the curves for all three markers simultaneously. In that
analysis, only CRP and NT- proBNP were found to be inde-
pendently predictive of the composite event, with significant
associations for each of the current underlying values and
slopes of these markers. In the model for the area under the
curves, only NT- proBNP was significant.
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8 Discussion
In this paper, we presented a novel approach for fitting joint
models, which allows for the inclusion of multivariate longi-
tudinal outcomes with realistic computing times. We demon-
strated once again the bias of the estimated parameters for
the survival process characteristic of the standard two-stage
approach and proposed the use of an importance-sampling-
corrected two-stage approach, with updated random effects,
in its place. Our approach was shown to be successful, pro-
ducing satisfactory results in a number of simulation scenar-
ios: both survival and longitudinal estimates were unbiased,
and computing times were reduced by several orders of mag-
nitude, compared to the full multivariate joint model. We
were easily able to incorporate multiple outcomes in the anal-
ysis of the Bio-SHiFT data, obtaining very similar results to
those previously noted for the CHF-related biomarkers (CRP,
HsTNT and NT-proBNP). We did not find any significant
associations between any of the renal markers (CysC, NAG
and KIM-1) and the risk of the composite event in the mul-
tivariate analysis, indicating that their predictive value may
not be independent of the CHF-related markers. While the
simulations included up to six multiple outcomes of vary-
ing types, it would be interesting to confirm our results in
even more complex settings, (perhaps incorporating compet-
ing risks such as those present in the Bio-SHiFT study) and to
try determining the limits of the methodology. A further topic
for research would be methods for increasing the speed of
computation involved in fitting the multivariate mixed model
itself, so as to extend the number of outcomes even further.
The proposed importance-sampling-corrected two-stage
estimation approach is implemented in function
mvJointModelBayes() in the freely available pack-
age JMbayes (version 0.8-0) for the R programming lan-
guage (freely available from the Comprehensive R Archive
Network at http://cran.r-project.org/package=JMbayes). An
example of how these functions should be used can be found
in the appendix.
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Appendices
A simulation study design
A.1 Scenario I
Scenario I simulates 500 patients with a maximum of 15
repeated measurements per patient. We included K = 2
continuous longitudinal outcomes and one survival outcome.
The k longitudinal outcomes each had form:
yki (t) = ηki (t) + ki (t)
= βk0 + βk1 × time + βk2 × group
+ βk3 × interaction
+ bki0 + bki1 × time + ki (t),
with ki (t) ∼ N (0, σ 2k ) and bki = (bki0, bki1)T , with bi =
(bT1i , b
T
2i )
T ∼ MV N (0, D). The variance-covariance matrix
D has general form:
D =
⎡
⎢
⎢⎢
⎣
D1 · · · Delse
· · · D2 · · ·
· · · . . . · · ·
· · · Dk
⎤
⎥
⎥⎥
⎦
, Dk =
[
Dk11 Dk12
Dk21 Dk22
]
and for Scenario I:
D1 = D2 =
[
0.68 −0.08
−0.08 0.28
]
, with Delse = 0.10
Time was simulated from a uniform distribution between 0
and 25. For the survival outcome, adjusting for group allo-
cation, we used:
hi (t) = h0(t) exp
[
γ0 + γ1 × group +
K∑
k=1
αkηki (t)
]
= h0(t) exp
[
γ0 + γ1 × group + α1η1i (t) + α2η2i (t)
]
.
The baseline risk was simulated from a Weibull distribution
h0(t) = φtφ−1, with φ = 1.65. For the simulation of the
censoring times, an exponential censoring distribution was
selected, with mean μ = 15, such that the censoring rate
was between 60% and 70%. More details are presented in
Table 6.
A.2 Scenario II
Scenario II is an extension of Scenario I such that we now
have K = 6 continuous longitudinal outcomes. We again
simulate 500 patients with a maximum of 15 repeated mea-
surements per patient. The k longitudinal outcomes each had
form:
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yki (t) = ηki (t) + ki (t)
= βk0 + βk1 × time + βk2 × group
+ βk3 × interaction
+ bki0 + bki1 × time + ki (t),
with ki (t) ∼ N (0, σ 2k ) and bki = (bki0, bki1)T , with bi =
(bT1i , b
T
2i , . . . , b
T
6i )
T ∼ MV N (0, D),
D1 = D2 =
[
0.97 0.78
0.07 0.032
]
, D3 = D4 =
[
0.13 −0.009
−0.009 0.002
]
,
D5 = D6 =
[
0.56 0.05
0.05 0.03
]
, and Delse = 0.00
Time was simulated from a uniform distribution between
0 and 25. For the survival outcome, adjusting for group allo-
cation as in Scenario I, we used:
hi (t) = h0(t) exp
[
γ1 × group +
K∑
k=1
αkηki (t)
]
.
The baseline risk was simulated using B-splines with knots
specified a priori. An exponential censoring distribution was
used for the simulation of the censoring times, with mean
μ = 15, such that the censoring rate was between 60% and
70%. Further details are again available in Table 6.
A.3 Scenario III
In Scenario III, we simulate 500 patients with a maximum of
15 repeated measurements per patient, including three con-
tinuous and three binary longitudinal outcomes such that:
gk
[
E{yki (t) | bki }
] = ηki (t)
= βk0 + βk1 × time + βk2 × group + βk3 × interaction
+ bki0 + bki1 × time,
where gk(·) denotes the canonical link function appro-
priate to the response type (identity and logit for the
Gaussian and binomial outcomes, respectively), and bi =
(bT1i , b
T
2i , . . . , b
T
6i )
T ∼ MV N (0, D), with
D1 = D2 =
[
0.97 0.78
0.07 0.032
]
, D3 = D4 =
[
0.13 −0.009
−0.009 0.002
]
,
D5 = D6 =
[
0.56 0.05
0.05 0.03
]
, and Delse = 0.00
For the survival outcome, adjusting for group allocation,
we again used:
hi (t) = h0(t) exp
[
γ1 × group +
K∑
k=1
αkηki (t)
]
.
Scenario III maintains the use of the uniform distribu-
tion between 0 and 25 for time and the use of B-splines for
the simulation of the baseline hazard. The censoring times
were simulated using an exponential censoring distribution
as before, with mean μ = 15. Table 6 provides additional
information.
B Example R Code
The below code fits a multivariate joint model for K = 3
longitudinal outcomes: y1, y2 and y3, where y1 is binary and
both y2 and y3 are continuous. We fit a linear mixed model for
y1 with random intercept and slope (time is f utime) and use
natural cubic splines with two knots, (at f utime = 6 and
f utime = 15 respectively) in both the fixed and random
parts of the models for y2 and y3. The survival submodel
adjusts for continuous baseline predictors x1 and x2.
# LIBRARIES: JMbayes, splines, survival
# MULTIVARIATE MIXED MODEL
MixedModel <-
mvglmer(list(y1 ˜ futime + (futime | id),
y2 ˜ ns(futime, knots = c(6, 15),
Boundary.knots = c(0, 27)) +
(ns(futime, knots = c(6, 15),
Boundary.knots = c(0, 27)) | id),
y3 ˜ ns(futime, knots = c(6, 15),
Boundary.knots = c(0, 27)) +
(ns(futime, knots = c(6, 15),
Boundary.knots = c(0, 27)) | id)),
data = longit,
families =
list(binomial, gaussian, gaussian))
# SURVIVAL SUB MODEL
SurvFit <- coxph(Surv(months, pe) ˜ x1 + x2,
data = surv,
model = TRUE)
# MULTIVARIATE JOINT MODEL
JointFitAll <- mvJointModelBayes(MixedModel,
SurvFit,
timeVar = "futime")
summary(JointFitAll, TRUE)
# , TRUE is necessary to obtain the
importance-sampling weighted estimates
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C Tables
See Tables 4, 5, 6 and 7.
Table 4 Simulation results for parameters of the longitudinal submodel
(Scenario II)
Parameter True Bias RMSE Coverage
Y1: Intercept 0.73 0.00001 0.06 0.96
Y1: Group − 0.30 0.00000 0.09 0.95
Y1: Interaction − 0.07 − 0.00001 0.02 0.92
Y1: Time 0.24 0.00001 0.01 0.95
Y1: Sigma 0.34 0.00000 0.00 0.95
Y2: Intercept 0.73 0.00001 0.06 0.94
Y2: Group − 0.30 0.00000 0.09 0.93
Y2: Interaction − 0.07 0.00000 0.02 0.97
Y2: Time 0.24 0.00001 0.01 0.96
Y2: Sigma 0.34 0.00001 0.00 0.96
Y3: Intercept 5.75 0.00000 0.02 0.96
Y3: Group 0.04 0.00000 0.03 0.95
Y3: Interaction 0.013 0.00000 0.00 0.96
Y3: Time 0.07 0.00000 0.00 0.96
Y3: Sigma 0.19 0.00000 0.00 0.96
Y4: Intercept 5.75 − 0.00001 0.02 0.96
Y4: Group 0.04 0.00001 0.03 0.95
Y4: Interaction 0.013 0.00001 0.00 0.95
Y4: Time 0.07 0.00001 0.00 0.96
Y4: Sigma 0.19 0.00000 0.00 0.94
Y5: Intercept 10.97 − 0.00001 0.06 0.95
Y5: Group − 0.42 0.00000 0.09 0.95
Y5: Interaction 0.01 0.00000 0.02 0.95
Y5: Time 0.22 0.00000 0.01 0.96
Y5: Sigma 1.06 0.00001 0.01 0.93
Y6: Intercept 10.97 − 0.00001 0.07 0.94
Y6: Group − 0.42 0.00001 0.09 0.94
Y6: Interaction 0.01 0.00001 0.02 0.95
Y6: Time 0.22 0.00001 0.01 0.95
Y6: Sigma 1.06 0.00000 0.01 0.94
Table 5 Simulation results for parameters of the longitudinal submodel
(Scenario III)
Parameter True Bias RMSE Coverage
Y1: Intercept 10.98 0.00002 0.07 0.97
Y1: Group − 0.45 0.00000 0.11 0.95
Y1: Interaction 0.05 − 0.00001 0.02 0.94
Y1: Time 0.21 0.00002 0.01 0.95
Y1: Sigma 1.10 − 0.00001 0.01 0.95
Y2: Intercept 10.98 0.00001 0.07 0.97
Y2: Group − 0.45 − 0.00001 0.11 0.96
Y2: Interaction 0.05 − 0.00001 0.02 0.95
Y2: Time 0.21 0.00001 0.01 0.96
Y2: Sigma 1.10 0.00002 0.01 0.96
Y3: Intercept 10.98 − 0.00001 0.05 0.93
Y3: Group − 0.45 0.00000 0.07 0.94
Y3: Interaction 0.05 0.00000 0.01 0.93
Y3: Time 0.21 0.00001 0.01 0.93
Y3: Sigma 1.10 0.00000 0.01 0.94
Y4: Intercept 1.11 − 0.00002 0.10 0.94
Y4: Group − 1.09 0.00001 0.13 0.95
Y4: Interaction 0.01 0.00002 0.02 0.93
Y4: Time 0.14 0.00001 0.02 0.93
Y5: Intercept 1.11 0.00000 0.12 0.95
Y5: Group − 1.09 0.00000 0.15 0.97
Y5: Interaction 0.01 0.00000 0.03 0.96
Y5: Time 0.14 − 0.00002 0.03 0.94
Y6: Intercept 1.11 − 0.00001 0.12 0.95
Y6: Group − 1.09 − 0.00001 0.15 0.96
Y6: Interaction 0.01 0.00001 0.03 0.96
Y6: Time 0.14 0.00002 0.03 0.93
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Table 6 Simulation scenarios Scenario Y αk βk = (βk0, βk1, βk2, βk3) σk γ k = (γk0, γk1)
I 1 0.64 (2.13, 0.24, −0.25, −0.05) 0.60 (−5.8, 0.48)
2 − 0.64
II 1 1.09 (0.73, 0.24, −0.30, −0.07) 0.34 (na, −0.20)
2 − 1.09
3 − 0.92 (5.75, 0.07, 0.04, 0.013) 0.19 (na, −0.20)
4 0.92
5 0.43 (10.97, 0.22, −0.42, 0.01) 1.06 (na, −0.20)
6 − 0.43
III 1 0.17 (10.98, 0.21, −0.45, 0.05) 1.10 (na, −0.47)
2 − 0.17
3 0.17
4 − 0.17 (1.11, 0.14, −1.09, 0.01) na (na, −0.47)
5 0.47
6 − 0.47
Table 7 Parameter estimates
and 95% credibility intervals
under the joint modeling
analysis for the Bio-SHiFT data
(Model 1)
Longitudinal process
Est. (95% CI) Est.* p value
Cystatin C
Intercept −0.36 (−0.42 to −0.31) − 0.38 <0.0001
Time (years since baseline) −0.04 (−0.07 to −0.01) − 0.05 0.004
σ 0.43 (0.42 to 0.45) 0.43 <0.0001
NAG
Intercept 2.46 (2.34 to 2.58) 2.42 <0.0001
Time (years since baseline) −0.06 (−0.13 to 0.00) − 0.07 0.058
σ 0.93 (0.90 to 0.97) 0.93 <0.0001
KIM-1
Intercept 8.93 (8.78 to 9.07) 8.99 <0.0001
Time (years since baseline) 0.01 (−0.05 to 0.08) 0.02 0.690
σ 0.85 (0.82 to 0.88) 0.81 <0.0001
CRP
Intercept 1.06 (0.87 to 1.26) 1.05 <0.0001
Bn(T ime, λ1) 0.96 (0.65 to 1.26) 1.18 <0.0001
Bn(T ime, λ2) 0.50 (0.31 to 0.69) 0.35 <0.0001
σ 1.00 (0.96 to 1.04) 0.99 <0.0001
HsTNT
Intercept 4.17 (4.02 to 4.32) 4.17 <0.0001
Bn(T ime, λ1) 0.17 (0.05 to 0.29) 0.26 0.010
Bn(T ime, λ2) 0.17 (0.10 to 0.26) 0.17 <0.0001
σ 0.28 (0.27 to 0.29) 0.29 <0.0001
NTS-proBNP
Intercept 6.78 (6.54 to 7.01) 6.59 <0.0001
Bn(T ime, λ1) 0.00 (−0.17 to 0.18) 0.12 1.000
Bn(T ime, λ2) −0.04 (−0.30 to 0.23) 0.05 0.750
Bn(T ime, λ3) 0.17 (0.03 to 0.34) 0.23 0.010
σ 0.50 (0.48 to 0.52) 0.50 <0.0001
Est.* are the estimates after importance sampling
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D Figures
See Figs. 4, 5, 6 and 7.
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Fig. 4 Simulation results from 500 datasets comparing the importance-
sampling-corrected two-stage approach with and without updated
random effects with the full multivariate joint model. The boxplots
show the mean computational time per approach (in minutes)
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Fig. 5 Simulation results from 500 datasets comparing the simple
two-stage approach and the importance-sampling-corrected two-stage
approach with the full multivariate joint model. The panels show the
posterior means from the 500 datasets for the coefficients from the two
longitudinal outcomes in Scenario I. The dashed horizontal line indi-
cates the true value of the coefficients
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random effects with the full multivariate joint model. The panels show
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Fig. 7 Longitudinal profiles of
continuous biomarkers (log base
2) for a randomly selected
subset of individuals from the
Bio-SHiFT cohort study that
did/did not experience the
primary event of interest
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